Karuna Therapeutics, Inc. (KRTX) News
Filter KRTX News Items
KRTX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KRTX News Highlights
- KRTX's 30 day story count now stands at 21.
- Over the past 7 days, the trend for KRTX's stories per day has been choppy and unclear. It has oscillated between 1 and 13.
- BMY, DRUG and DOW are the most mentioned tickers in articles about KRTX.
Latest KRTX News From Around the Web
Below are the latest news stories about KARUNA THERAPEUTICS INC that investors may wish to consider to help them evaluate KRTX as an investment opportunity.
Biotech Stock Roundup: BMY's KRTX and RYZB Acquisition, CYTK Surges on Study DataBristol Myers (BMY) and Cytokinetics (CYTK) are in the news on acquisition announcements and study updates, respectively. |
Bristol Myers (BMY) to Buy Cancer Drug-Maker RayzeBio for $4.1BBristol Myers (BMY) is set to acquire RayzeBio for $4.1 billion to strengthen and diversify its already established oncology portfolio. The transaction is expected to close in the first half of 2024. |
Trending tickers: Intel | Tencent | RayzeBio | AstrazenecaThe latest investor updates on stocks that are trending on Wednesday. |
Why Is RayzeBio (RYZB) Stock Up 100% Today?RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio. |
Bristol Myers buying RayzeBio, FedEx buyback: Trending tickersFedEx (FDX) shares rose after the shipping giant announced a $1 billion accelerated share buyback plan. Shares of RayzeBio (RYZB) jumped 100% after it was announced the company was being acquired by Bristol Myers Squibb (BMY) in a $4.1 billion deal. It's Bristol Myers' second deal in less than a week. On Friday, the company announced it was acquiring Karuna Therapeutics (KRTX) in a $14 billion deal. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. |
Karuna (KRTX) Up 48% on $14B Buyout Offer From Bristol MyersBristol Myers (BMY) is set to acquire Karuna (KRTX) for $330 per share. This transaction is expected to close in the first half of 2024. |
Karuna downgraded, Arm target raised: Wall Street's top analyst callsKaruna downgraded, Arm target raised: Wall Street's top analyst calls |
3 Charts For Investors to Watch Tuesday: Bitcoin, Oil, XBI ETFThese 3 charts are worth watching on Tuesday. We look at the reasons why and identify important technical levels to watch. |
Stock Market Closes Mixed But Indexes Post Weekly Gains; The Dow Got Coal TodayThe stock market major indexes closed mixed on Friday ahead of the long weekend. Chinese gaming stocks sold off while biotech stocks rallied. |
Bristol's $14 Billion Takeover Of Karuna Pulled A Bevy Of Stocks HigherBristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere. |